Suppression of Inflammatory and Allergic Responses by Pharmacologically Potent Fungus Ganoderma lucidum

E-ISSN： 2212-2710|8|2|104-117

ISSN： 1872-213X

Source： Recent Patents on Inflammation & Allergy Drug Discovery, Vol.8, Iss.2, 2014-05, pp. : 104-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Bacterial DNA in Inflammatory and Allergic Disease

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 2, Iss. 2, 2008-01 ,pp. : 117-122

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Tetracyclines on IgE Allergic Responses and Asthma

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 5, Iss. 3, 2011-09 ,pp. : 221-228

Bentham Science Publishers

Access to resources Recommend Favorite

Vcsa1 Gene Peptides for the Treatment of Inflammatory and Allergic Reactions

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 1, Iss. 2, 2007-06 ,pp. : 124-132

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Chemokine Receptor-Targeted Depletion of Pathological Cells as A Therapeutic Strategy for Inflammatory, Allergic and Autoimmune Diseases

Recent Patents on Inflammation & Allergy Drug Discovery, Vol. 3, Iss. 3, 2009-11 ,pp. : 177-187

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulatory and Anti-cancer Properties of Pharmacologically Relevant Mushroom Glycans

Recent Patents on Biotechnology, Vol. 10, Iss. 1, 2016-09 ,pp. : 72-78

Bentham Science Publishers

Access to resources Recommend Favorite